Associate Dir-Marketing(GI/HBC)-OBU New Assets-上海

This role needs to take lead in one tumor area including all assets in this disease area. In addition, this role also needs to be responsible for one pan-cancer molecule across DAs to have overall compound strategy, shapes Target Product Profiles (TPPs), defines segmentation and positioning, co-develop access strategy in China, informs evidence generation, and leads cross-functional alignment, such as global strategy, forecasting team, China R&D, China medical, market access and commercial team, etc. Leading strategy and tactics to bridge existing AZ presence in specific oncology disease area into future new launchings launches by partnering with cross function team to secure non-regrettable new launches & LCM.